Research Papers

25 of 735 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
Dynamic whole-body [<sup>18</sup>F]FES PET/CT increases lesion visibility in patients with metastatic breast cancer.
Pedersen MA; Munk OL; Dias AH; Steffensen JH; Møller AL; Johnsson AL; Hansen KV; Bender D; Jakobsen S; Busk M; Gormsen LC; Tramm T; Borgquist S; Vendelbo MH.
EJNMMI Res (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Pharmacodynamics and biodistribution of [195mPt]cisplatin(CISSPECT®) in head and neck squamous cell carcinoma.
de Roest RH; Stigter van Walsum M; van der Schilden K; Brakenhoff RH.
EJNMMI Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The efficacy of short acquisition time using <sup>18</sup>F-FDG total-body PET/CT for the identification of pediatric e…
Li M; Cui X; Yue H; Ma C; Li K; Chai L; Ge M; Li H; Ng YL; Zhou Y; Shi J; Duan Y; Cheng Z.
EJNMMI Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Synthesis and preclinical evaluation of [<sup>11</sup>C]EAI045 as a PET tracer for imaging tumors expressing mutated ep…
Högnäsbacka AA; Poot AJ; Plisson C; Bergare J; Bonsall DR; McCluskey SP; Wells LA; Kooijman E; Schuit RC; Verlaan M; Beaino W; van Dongen GAMS; Vugts DJ; Elmore CS; Passchier J; Windhorst AD.
EJNMMI Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Spherization indices measured by resting SPECT improve risk stratification in patients with ischemia with non-obstructi…
Zhao Y; Hu Y; Li Y; Wang Y; Xiao Y; Xu L; Ren T; Wu Q; Wang R; Wu Z; Li S; Wu P.
EJNMMI Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Risk of treatment-altering haematological toxicity and its dependence on bone marrow doses in peptide receptor radionuc…
Persson M; Hindorf C; Ardenfors O; Larsson M; Nilsson JN.
EJNMMI Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
The image quality and feasibility of solitary delayed [<sup>68</sup> Ga]Ga-PSMA-11 PET/CT using long field-of-view scan…
Yu X; Xu L; Huang G; Liu J; Chen R; Chen Y.
EJNMMI Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
<sup>18</sup>F-ASEM PET/MRI targeting alpha7-nicotinic acetylcholine receptor can reveal skeletal muscle denervation.
Kim YI; Lee SH; Jung JH; Kim SY; Ko N; Lee SJ; Oh SJ; Ryu JS; Ko D; Kim W; Kim K.
EJNMMI Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
PSMA imaging as a non-invasive tool to monitor inducible gene expression in vivo.
Simunic M; Joshi JT; Merkens H; Colpo N; Kuo HT; Lum JJ; Bénard F.
EJNMMI Res (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
[<sup>68</sup> Ga]Ga-FAPI-04 PET/CT may be a predictor for early treatment response in rheumatoid arthritis.
Pan Q; Yang H; Zhou Z; Li M; Jiang X; Li F; Luo Y; Li M.
EJNMMI Res (Unknown)
Published: 2024
4/6 Transparent
Registered Funding Declared
Advancements in theranostic applications: exploring the role of fibroblast activation protein inhibition tracers in enh…
Wang Y; Liu Y; Geng H; Zhang W.
EJNMMI Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Characterization of a novel model for atherosclerosis imaging: the apolipoprotein E-deficient rat.
Sijbesma JWA; van Waarde A; Kristensen S; Kion I; Tietge UJF; Hillebrands JL; Bulthuis MLC; Buikema H; Nakladal D; Westerterp M; Liu F; Boersma HH; Dierckx RAJO; Slart RHJA.
EJNMMI Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Assessment of hypoxia and oxidative-related changes in a lung-derived brain metastasis model by [<sup>64</sup>Cu][Cu(AT…
Fantin J; Toutain J; Pérès EA; Bernay B; Mehani SM; Helaine C; Bourgeois M; Brunaud C; Chazalviel L; Pontin J; Corroyer-Dulmont A; Valable S; Cherel M; Bernaudin M.
EJNMMI Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Development of [<sup>89</sup>Zr]Zr-hCD103.Fab01A and [<sup>68</sup>Ga]Ga-hCD103.Fab01A for PET imaging to noninvasively…
Fan X; Ważyńska MA; Kol A; Perujo Holland N; Fernandes B; van Duijnhoven SMJ; Plat A; van Eenennaam H; Elsinga PH; Nijman HW; de Bruyn M.
EJNMMI Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
An update on the use of image-derived input functions for human PET studies: new hopes or old illusions?
Volpi T; Maccioni L; Colpo M; Debiasi G; Capotosti A; Ciceri T; Carson RE; DeLorenzo C; Hahn A; Knudsen GM; Lammertsma AA; Price JC; Sossi V; Wang G; Zanotti-Fregonara P; Bertoldo A; Veronese M.
EJNMMI Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Effects of novel androgen receptor signaling inhibitors on PSMA PET signal intensity in patients with castrate-resistan…
Sonni I; Gafita A; Unterrainer LM; Alano RM; Lira S; Shen J; Drakaki A; Grogan T; Rettig MB; Czernin J; Calais J.
EJNMMI Res (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Head-to-head comparison of relative cerebral blood flow derived from dynamic [<sup>18</sup>F]florbetapir and [<sup>18</…
Tuncel H; Visser D; Timmers T; Wolters EE; Ossenkoppele R; van der Flier WM; van Berckel BNM; Boellaard R; Golla SSV.
EJNMMI Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Quantitative and clinical implications of the EARL2 versus EARL1 [<sup>18</sup>F]FDG PET-CT performance standards in he…
Cox MC; Jurcka T; Arens AIJ; van Rijk MC; Kaanders JHAM; van den Bosch S.
EJNMMI Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Assessment of resting myocardial blood flow in regions of known transmural scar to confirm accuracy and precision of 3D…
Bober RM; Milani RV; Kachur SM; Morin DP.
EJNMMI Res (Unknown)
Published: 2023
4/6 Transparent
Registered Funding Declared
Dispersion-corrected extracorporeal arterial input functions in PET studies of mice: a comparison to intracorporeal mic…
Cufe J; Gierse F; Schäfers KP; Hermann S; Schäfers MA; Backhaus P; Büther F.
EJNMMI Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
CYP3A4 inhibitors do not influence [<sup>68</sup>Ga]Ga-DOTA-TATE uptake in liver tissue.
Chahid Y; Chahid F; van de Garde E; Booij J; Verberne HJ; Hendrikse NH.
EJNMMI Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Noradrenaline transporter PET reflects neurotoxin-induced noradrenaline level decrease in the rat hippocampus.
Sakai T; Hattori S; Ogata A; Yamada T; Abe J; Ikenuma H; Ichise M; Suzuki M; Ito K; Kato T; Kimura Y.
EJNMMI Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
Fc-engineered monoclonal antibodies to reduce off-target liver uptake.
Mangeat T; Gracia M; Pichard A; Poty S; Martineau P; Robert B; Deshayes E.
EJNMMI Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
3D-printed dual holder system for simultaneous rat PET scanning: design and influence on quantification.
Bouillot C; Daligault S; Bolbos R; Costes N; Zimmer L.
EJNMMI Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared
A dual-tracer approach using [<sup>11</sup>C]CH and [<sup>18</sup>F]FDG in HCC clinical decision making.
Veenstra EB; Ruiter SJS; de Haas RJ; de Jong KP; Erba PA; Dierckx RAJO; Noordzij W.
EJNMMI Res (Unknown)
Published: 2023
3/6 Transparent
Funding Declared